Recent Study of Turmeric in Combination with Garlic as Antidiabetic Agent

The aim of this study was to compare efficacy and safety of Allium Curcuma with glibenclamide in type-2 diabetes mellitus with or without dyslipidemia. Thirty five patients were recruited and randomized into 2 groups for 14 weeks treatment and assessment. One group received study drug, three times two capsules containing 200 mg turmeric and 200 mg allium extract per day. The other group received 1 capsule of 5 mg glibenclamide as standard drug per day. After 14 weeks of treatment patients with allium curcuma treatment showed significant decreased in fasting blood glucose (192.76 versus 141.71 mg/dL) and 2 hours post-prandial blood glucose (295.35 versus 204.35 mg/dL). HbA1C level was also significantly decreased (10.41 versus8.09). No difference was found in blood pressure, hematology profile, liver and kidney function of both groups. In conclusion, allium curcuma has potential to be used as antidiabetic agent.